It’s called SenSight * and it’s an anti-Parkinson’s ‘pacemaker’, a directional lead system developed by Medtronic for Deep Brain Stimulation (Dbs) therapy. “A directional stimulation that allows you to customize the therapy, and to provide individual and patient-specific data thanks to the sensing function for detecting brain signals”: these, explains the company, are the innovative features of the new device, used together with the neurostimulator. Percept * PC introduced to the market last year.
Read Also
- Covid, Tarantino (Si-Guida): ‘It has aggravated the state of patients with musculoskeletal pain’ Sep 17, 2021
- Alejandro Gaviria decides on a campaign for the second round: “it is not time for neutrality” Jun 3, 2022
- Gender-based violence: Demonstrations in several cities against the “impunity” of the attackers Nov 19, 2022
- They return 8 Dominicans and 15 Haitians who tried to arrive illegally in Puerto Rico May 27, 2022
- Twitter: Elon Musk announces reinstatement of suspended accounts Nov 24, 2022
- Online classes split families between the internet and hunger Jul 1, 2021
- UeD: the first photos of the new décolleté of the controversial Turin lady Gemma Galgani finally appear on the web Aug 30, 2021